LIVE SESSION BRIEF Biotechnology $10.49B Cap Quant: HOLD

Ionis Pharmaceuticals, Inc. (IONS) — Live Session & Technical Brief

Updated Nov 16, 2026 2:36 PM ET · Prev Close $29.06

Pro Workspace
Last Session Price
$28.57 -1.70%
-$0.49 vs $29.06 prior close
Intraday Range
$28.24 – $29.99
Open $29.90
Relative Volume
0.58x Avg
2,604,577 sh
52-Week Range
$27.25 – $86.74
Benchmark Alpha
+0.19% vs SPY
+0.72% vs QQQ
20-Session Trend -37.1%

Session Regime & Catalyst Assessment

64% Signal Conviction
TECHNICAL 64% Driver Weight

Controlled Session Consolidation (-1.70%) in Biotechnology

Ionis Pharmaceuticals, Inc. (IONS) is trading within a tight intraday band at $28.57 (-1.70%, 0.58x relative volume), signaling orderly institutional price discovery without an outlier shock. Relative to benchmarks, IONS is trading in line with the S&P 500 (+0.19% alpha). 14-day RSI stands at 23.7, keeping momentum in a oversold regime.

NEWS 70% Weight
The Strategy Exited Ionis Pharmaceuticals IONS Following Sequential Phase 3 Clinical Setbacks

Artisan Partners, an investment management company, released its third-quarter 2026 investor letter for the Artisan U.S. Small-Cap Growth Strategy . The letter can be downloaded here. Global equities reached new highs de

TECHNICAL 68% Weight
Moving Average Structure: Bearish Alignment

Price ($28.57) trades relative to 20-day SMA ($38.46) and 50-day SMA ($43.07).

Volume Confirmation
LOW VOLUME (0.58x) Consolidation
Sub-average participation — monitor RVOL expansion above 1.2x.
Composite Catalyst Confidence 64%
Cross-checked across volume tape, benchmark alpha, options flow, and news.

Market & Sector Relative Strength

IONS trading in line with the S&P 500 (+0.19% alpha)
IONS Session
-1.70%
$28.57
S&P 500 (SPY)
-1.89%
$740.11
Nasdaq 100 (QQQ)
-2.42%
$663.44
Healthcare (XLV)
-0.38%
$188.14
Alpha vs SPY: +0.19% Alpha vs QQQ: +0.72% Alpha vs XLV: -1.32%

Recent IONS Catalyst Headlines

Verified Wire

1–3 Day Expected Range & Key Level

48% Follow-Through
Lower Bound
$27.40
Short-term support band
Upper Bound
$29.74
Short-term resistance band
Key Inflection Level
$28.24 (session support)

Monitor volume expansion above 1.5x RVOL around $28.24 (session support) for directional breakout confirmation.

Technical Regime (IONS)

BEARISH MA TREND
RSI (14)
23.7
Oversold
20-Day SMA
$38.46
Below 20d
50-Day SMA
$43.07
Below 50d
MACD Signal
Bearish
MACD -4.60
ADX (14)
44.4
Strong trend
10d Momentum
-12.68
Strong downward 10-day pressure

Retail & Crowd Sentiment

Very Bullish
24h Messages
1
7d avg 2.3
Bullish / Bearish
100.0% / 0.0%
Low buzz
Crowd Discussion Digest

Artisan Partners exited its investment in Ionis Pharmaceuticals (IONS) following sequential Phase 3 clinical setbacks, according to its Q3 2026 investor letter.

Reddit communities: 1 comment (Bearish)

About Ionis Pharmaceuticals, Inc.

Ionis Pharmaceuticals is the leading developer of antisense technology to discover and develop novel drugs. Its broad clinical and preclinical pipeline targets a wide variety of diseases, with an emphasis on cardiovascular, metabolic, neurological, and rare diseases. Ionis and Biogen brought Spinraza to market in 2016 as a treatment for spinal muscular atrophy, and Biogen …

Sector
Healthcare
Market Cap
$10.49B
Forward P/E
90.9x
Employees
927

Get Instant IONS Catalyst Alerts

Receive an email alert when IONS triggers an unusual volume breakout, options sweep, or rating shift.

Other Liquid Stocks Moving Today

All Today's Movers

IONS Session & Catalyst FAQ

Why is IONS stock trading near flat today?

Ionis Pharmaceuticals, Inc. (IONS) is trading within a tight intraday band at $28.57 (-1.70%, 0.58x relative volume), signaling orderly institutional price discovery without an outlier shock. Relative to benchmarks, IONS is trading in line with the S&P 500 (+0.19% alpha). 14-day RSI stands at 23.7, keeping momentum in a oversold regime.

Is IONS stock a buy or sell right now?

Today's session carries a 64% catalyst conviction score on 0.58x relative volume (low participation). Our multi-factor model currently rates IONS as HOLD. Review full valuation, quality, and timing signals on the IONS Buy or Sell Decision Brief →

What is IONS's intrinsic value and expected trading range?

At $28.57, IONS's modeled 1-to-3 session range is $27.40 – $29.74, with a key inflection level at $28.24 (session support). Compare current price against multi-year cash flow projections in the IONS Intrinsic Value & DCF Model → and Market Cycle Phase Tracker →

What do RSI and moving averages signal for IONS?

RSI at 23.7 indicates oversold conditions — watch for mean-reversion support. IONS trades at $28.57 relative to its 20-day SMA ($38.46) and 50-day SMA ($43.07), reflecting a bearish moving-average structure.

Tradestie Flagship Research & Market Hubs